Loading stock data...

Vivo Bio Tech Limited

BSE: VIVOBIOT

BSE
27.32 -0.51 (-1.83%)

Prev Close

27.83

Open Price

27

Volume

13,250

Today Low / High

27 / 28.49

52 WK Low / High

25.2 / 44.9

Range

26 - 29

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 27.32, reflecting a change of -0.51 (-1.83255%). The expected target range on the BSE is 26 - 29. The stock is showing a downward trend on the BSE. This could indicate a potential risk for investors who are considering buying at this moment.

25 Feb 27.00 1.19%
24 Feb 29.55 -5.82%
23 Feb 28.32 -1.41%
20 Feb 28.73 -1.43%
19 Feb 31.74 -10.37%
18 Feb 27.90 0.11%
17 Feb 28.94 -1.62%
16 Feb 28.39 -0.32%
13 Feb 28.99 -2.07%
12 Feb 29.39 -2.79%
11 Feb 28.25 2.30%
10 Feb 28.05 3.39%
09 Feb 28.05 1.25%
06 Feb 28.17 1.06%
05 Feb 30.00 -6.27%
04 Feb 29.30 -1.13%
03 Feb 28.89 1.42%
02 Feb 28.85 -0.21%
01 Feb 27.30 4.18%
30 Jan 27.25 0.18%
29 Jan 27.02 0.41%
28 Jan 26.50 -0.30%

Vivo Bio Tech Limited Graph

Vivo Bio Tech Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Vivo Bio Tech Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 27.32, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 27.32 27.59 24.83 - 30.35
27.87 22.29 - 33.44
28.14 19.70 - 36.58
Bearish Scenario 27.32 27.05 24.34 - 29.75
26.77 21.42 - 32.13
26.50 18.55 - 34.45

Overview of Vivo Bio Tech Limited

ISIN

INE380K01017

Industry

Medical - Distribution

Vol.Avg

21,693

Market Cap

478,303,261

Last Dividend

0

Official Website

Visit Website

IPO Date

2024-12-30

DCF Diff

N/A

DCF

0

Financial Ratios Every Investor Needs

Stock Rating Details for VIVOBIOT

Metric Value Recommendation
Overall Rating C- Strong Sell
DCF Score 1 Strong Sell
ROE Score 1 Strong Sell
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 3 Neutral
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 46.67 Cr 5.79 Cr 40.88 Cr 0.8759 0.00 Cr 20.02 Cr 11.49 Cr 7.28 Cr 4.76 25.31 Cr 0.1560
2024-03-31 45.45 Cr 3.85 Cr 41.60 Cr 0.9153 0.00 Cr 5.88 Cr 11.99 Cr 2.53 Cr 1.70 21.13 Cr 0.0556
2023-03-31 52.23 Cr 6.77 Cr 45.46 Cr 0.8704 0.00 Cr 6.91 Cr 12.57 Cr 2.65 Cr 1.78 21.54 Cr 0.0507
2022-03-31 51.39 Cr 11.44 Cr 39.95 Cr 0.7774 0.00 Cr 7.41 Cr 8.74 Cr 2.20 Cr 1.56 15.91 Cr 0.0428
2021-03-31 51.78 Cr 7.21 Cr 44.57 Cr 0.8608 1.10 Cr 8.33 Cr 12.19 Cr 5.68 Cr 4.23 17.74 Cr 0.1097

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 1.28 Cr 143.23 Cr 65.33 Cr 77.9045 Cr 54.03 Cr 52.74 Cr 7.79 Cr 77.22 Cr 0.00 Cr 0.00 Cr 0.00 Cr 27.8401 Cr
2024-03-31 1.39 Cr 137.13 Cr 82.73 Cr 54.3995 Cr 73.06 Cr 71.67 Cr 8.77 Cr 81.46 Cr 0.00 Cr 0.00 Cr 0.00 Cr 37.9148 Cr
2023-03-31 1.37 Cr 123.03 Cr 71.16 Cr 51.8732 Cr 62.40 Cr 61.02 Cr 7.97 Cr 79.96 Cr 0.00 Cr 0.00 Cr 0.00 Cr 24.9692 Cr
2022-03-31 1.71 Cr 122.49 Cr 75.36 Cr 47.1322 Cr 67.44 Cr 65.73 Cr 9.81 Cr 82.41 Cr 0.00 Cr 0.00 Cr 0.00 Cr 23.1810 Cr
2021-03-31 1.17 Cr 79.52 Cr 36.99 Cr 42.5309 Cr 30.96 Cr 29.79 Cr 13.28 Cr 41.04 Cr 0.00 Cr 0.00 Cr 0.00 Cr 21.8369 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 11.8299 Cr -15.8418 Cr 3.9048 Cr -10.4404 Cr -0.1071 Cr 1.2089 Cr -22.2703 Cr 7.2826 Cr -6.8501 Cr 0.0000 Cr 0.0000 Cr
2024-03-31 15.5223 Cr -7.9500 Cr -7.5574 Cr 7.5723 Cr 0.0149 Cr 1.3895 Cr -7.9500 Cr 2.5263 Cr -1.3044 Cr 0.0000 Cr 0.0000 Cr
2023-03-31 14.8338 Cr -3.9975 Cr -11.1751 Cr 3.3697 Cr -0.3388 Cr 1.3712 Cr -3.9975 Cr 4.6208 Cr -6.9867 Cr 0.0000 Cr 0.0000 Cr
2022-03-31 15.0100 Cr -51.1116 Cr 36.6500 Cr -36.1000 Cr 0.5481 Cr 1.7100 Cr -51.1100 Cr 4.4700 Cr 35.4288 Cr 0.0000 Cr 0.0000 Cr
2021-03-31 14.1760 Cr -22.8218 Cr 8.7826 Cr -8.6458 Cr 0.1368 Cr 1.1654 Cr -22.8218 Cr 8.6197 Cr 4.9621 Cr 0.0000 Cr 0.0000 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-12-31 13.51 Cr 9.15 Cr 4.37 Cr 0.3231 2.83 Cr 1.25 Cr 0.56 5.49 Cr 0.0924
2025-09-30 13.11 Cr 8.74 Cr 4.37 Cr 0.3331 2.84 Cr 0.87 Cr 0.45 5.55 Cr 0.0663
2025-06-30 12.51 Cr 1.51 Cr 11.01 Cr 0.8796 2.85 Cr 1.34 Cr 0.74 5.63 Cr 0.1069
2025-03-31 12.29 Cr 0.77 Cr 11.52 Cr 0.9373 2.77 Cr 1.06 Cr 0.78 5.17 Cr 0.0865
2024-12-31 12.21 Cr 1.87 Cr 10.35 Cr 0.8472 3.29 Cr 0.82 Cr 0.60 5.55 Cr 0.0671

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-09-30 1.33 Cr 0.00 Cr 1.33 Cr 14.17 Cr 6.93 Cr 68.97 Cr 74.31 Cr 165.18 Cr 68.41 Cr
2025-06-30 0.00 Cr 0.00 Cr 1.28 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -77.90 Cr
2025-03-31 1.28 Cr 0.00 Cr 1.28 Cr 32.11 Cr 7.79 Cr 41.94 Cr 77.22 Cr 143.23 Cr 65.33 Cr
2024-12-31 0.00 Cr 0.00 Cr 1.37 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -59.80 Cr
2024-09-30 1.37 Cr 0.00 Cr 1.37 Cr 32.25 Cr 8.03 Cr 42.05 Cr 78.78 Cr 127.92 Cr 68.12 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-06-30 1.34 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2025-03-31 1.06 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-12-31 0.82 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 5.23 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 0.17 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
2012-09-25 September 25, 12 1:10

Similar Stocks: Medical - Distribution

Company Name Symbol Price Market Cap Volume
Entero Healthcare Solutions Limited ENTERO ₹1,060.90 ₹46,160,753,063.00 ₹53,697.00

Key Executives

Chief Executive Officer, President & Whole Time Director
Alangudi Sankaranarayanan

Gender: Not Specified

Year Born: 1943

Company Secretary & Compliance Officer
Ayinampudi Vaishnavi Kiran

Gender: male

Year Born:

Chief Business Officer
Chandrasekhar Patnaik

Gender: male

Year Born:

Whole Time Director
Kalyan Ram Mangipudi

Gender: male

Year Born: 1978

Head – Toxicology
Kandula Srinivasa Rao

Gender: male

Year Born:

Whole Time Director, Head - Operations & Chief Financial Officer
Sri Kalyan Kompella

Gender: male

Year Born: 1979

Founder & Advisor
Viswanath Kompella

Gender: male

Year Born: 1968

FAQs about Vivo Bio Tech Limited

Who is the CEO of the company?

The CEO is Alangudi Sankaranarayanan.

What is the current market price of the stock?

The current price is ₹27.32.

What is the 52-week price range?

The range is ₹25.2-44.9.

What is the market capitalization of the company?

The market capitalization is ₹47.83 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 13.37.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Vivo Bio Tech Limited (ISIN: INE380K01017) is a leading Medical - Distribution in India. With a market capitalization of ₹47.83 crores and an average daily volume of 21,693 shares, it operates in the Medical - Distribution. The company last declared a dividend of ₹0.